Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design

RG Everson, Y Hashimoto, JL Freeman… - Journal of neuro …, 2018 - Springer
Introduction Surgery and radiation therapy are the standard treatment options for
meningiomas, but these treatments are not always feasible. Expression profiling was …

[HTML][HTML] Evaluation of P57, P53 and Ki67 Expression in Meningiomas

İ Küçükosmanoğlu, MİE Karanis… - Journal of Korean …, 2022 - synapse.koreamed.org
Objective We conducted this study with the aim of predicting the biological behavior of
meningiomas, and determining the benefits of associating histological subtype and grade …

Assessment of candidate immunohistochemical prognostic markers of meningioma recurrence

T Csonka, B Murnyák, R Szepesi, J Bencze… - Folia …, 2016 - termedia.pl
Although tumour recurrence is an important and not infrequent event in meningiomas,
predictive immunohistochemical markers have not been identified yet. The aim of this study …

[HTML][HTML] Histopathological and immunohistochemical evaluation of meningiomas with reference to proliferative markers p53 and Ki-67

RB Telugu, AK Chowhan… - Journal of clinical and …, 2016 - ncbi.nlm.nih.gov
Materials and Methods A total of 224 meningiomas, diagnosed between January1995 and
October 2011were graded according to WHO 2007 criteria. Immunostaining for p53 and Ki …

Microvascularization of Grade I meningiomas: effect on tumor volume, blood loss, and patient outcome

M Karsy, B Burnett, A Di Ieva, MD Cusimano… - Journal of …, 2017 - thejns.org
OBJECTIVE Quantitative assessment of tumor microvascularity has the potential to improve
prognostication, advance understanding of tumor biology, and help narrow potential …

Clinicopathological and molecular characteristics of pediatric meningiomas

S Battu, A Kumar, P Pathak, S Purkait… - …, 2018 - Wiley Online Library
Molecular and clinical characteristics of pediatric meningiomas are poorly defined.
Therefore, we analyzed clinical, morphological and molecular profiles of pediatric …

Estrogen and progesterone receptor in meningiomas: an immunohistochemical analysis

RB Telugu, AK Chowhan… - Journal of Cancer …, 2020 - journals.lww.com
Background: Meningiomas are common slow-growing primary intracranial neoplasms
attached to the dura mater and are composed of neoplastic meningothelial cells. Increased …

Phosphoproteomic and kinomic signature of clinically aggressive grade I (1.5) meningiomas reveals RB1 signaling as a novel mediator and biomarker

CA Parada, JW Osbun, T Busald, Y Karasozen… - Clinical Cancer …, 2020 - AACR
Abstract Purpose: Most World Health Organization (WHO) grade I meningiomas carry a
favorable prognosis. Some become clinically aggressive with recurrence, invasion, and …

Expression of p40 (∆ Np63) protein in meningiomas, an unexpected finding: immunohistochemical study and evaluation of its possible prognostic role

E Guadagno, M Del Basso De Caro… - Journal of neuro …, 2016 - Springer
According to the 2007 WHO (World Health Organization) Classification, meningiomas are
divided into three grades of malignancy, with different recurrence rate, based exclusively on …

Progesterone and Estrogen Receptors in Meningiomas–A Clinicopathological Analysis

A Govindan, JP Alapatt - Journal of Cancer Research …, 2023 - neoplasiaresearch.com
Background: Meningiomas are common tumors of the Central Nervous System. Recurrence
in meningiomas has been proven to be associated with factors like extent of resection and …